ES2011186A6 - Procedimiento para la preparacion de composiciones farmaceuticas conteniendo moxonidina, hidroclotiazida, con o sin triamteren. - Google Patents
Procedimiento para la preparacion de composiciones farmaceuticas conteniendo moxonidina, hidroclotiazida, con o sin triamteren.Info
- Publication number
- ES2011186A6 ES2011186A6 ES8803579A ES8803579A ES2011186A6 ES 2011186 A6 ES2011186 A6 ES 2011186A6 ES 8803579 A ES8803579 A ES 8803579A ES 8803579 A ES8803579 A ES 8803579A ES 2011186 A6 ES2011186 A6 ES 2011186A6
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical products
- chloro
- phenylpteridine
- moxonidine
- benzothiadiazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Formation And Processing Of Food Products (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE COMPOSICIONES FARMACEUTICAS CONTENIENDO MOXONIDINA, HIDROCLOROTIAZIDA, CON O SIN TRIAMTEREN. PROCEDIMIENTO PARA LA PREPARACION DE COMPOSICIONES FARMACEUTICAS CONTENIENDO MOXONIDINA [4-CLORO-6-METOXI-2-METIL-5-(2-IMIDAZOLIN)-2-IL) AMINOPIRIDINA] O SUS SALES FARMACEUTICAMENTE EQUIVALENTES, E HIDROCLOROTIAZIDA (6-CLORO-3,4-DIHIDRO-2H-1,2,4-BENZOTIADIAZINA-7-SULFONAMIDA-1,1-DIOXIDO), CON O SIN TRIAMTEREN (2,4,7-TRIAMINO-6-FENILPTERIDINA). EL PROCEDIMIENTO CONSISTE EN HUMEDECER LA HIDROCLOROTIAZIDA, Y EVENTUALMENTE EL TRIAMTEREN, CON UNA SOLUCION DE MOXONIDINA, O UNA DE SUS SALES, EN UN DISOLVENTE ADECUADO, CON APORTE DE CALOR, PARA LOGRAR OBTENER UN GRANULADO, QUE SECA Y SE TRITURA. ESTE PRODUCTO TRITURADO PUEDE UTILIZARSE DIRECTAMENTE PARA LLENAR CAPSULAS, O PUEDE UTILIZARSE, CON LA ADICION DE LOS COADYUVANTES NECESARIOS, PARA PREPARAR COMPRIMIDOS POR PRESION. LOS PRODUCTOS OBTENIDOS TIENEN UNA VALIOSA APLICACION COMO DIURETICOS Y ANTIHIPERINTENSIVOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873739779 DE3739779A1 (de) | 1987-11-24 | 1987-11-24 | Pharmazeutische praeparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2011186A6 true ES2011186A6 (es) | 1989-12-16 |
Family
ID=6341139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES8803579A Expired ES2011186A6 (es) | 1987-11-24 | 1988-11-23 | Procedimiento para la preparacion de composiciones farmaceuticas conteniendo moxonidina, hidroclotiazida, con o sin triamteren. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4952410A (es) |
| EP (1) | EP0317855B1 (es) |
| JP (1) | JPH01193224A (es) |
| KR (1) | KR890007740A (es) |
| AT (1) | ATE70445T1 (es) |
| AU (1) | AU2566288A (es) |
| DE (2) | DE3739779A1 (es) |
| ES (1) | ES2011186A6 (es) |
| ZA (1) | ZA888818B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100221695B1 (ko) * | 1991-08-12 | 1999-09-15 | 그린 마틴, 브라이언 쥐 테슬리 | 약학적 구상 제형 |
| US5977121A (en) * | 1995-02-28 | 1999-11-02 | Eli Lilly And Company | Use of moxonidine for the treatment of atherosclerosis |
| US5994348A (en) | 1995-06-07 | 1999-11-30 | Sanofi | Pharmaceutical compositions containing irbesartan |
| CA2182851A1 (en) * | 1995-08-15 | 1997-02-16 | August Masaru Watanabe | Method for treating substance abuse withdrawal |
| GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
| AU9692898A (en) * | 1997-10-17 | 1999-05-10 | Eli Lilly And Company | Potentiation of pharmaceuticals |
| WO2000044355A1 (en) * | 1999-01-29 | 2000-08-03 | Eli Lilly And Company | Moxonidine salts |
| TR200102221T2 (tr) * | 1999-02-01 | 2002-01-21 | Solvay Pharmaceuticals Gmbh | Kalp krizi sonrası tedavileri için moksonidin kullanımı |
| AU2003257418A1 (en) * | 2002-06-19 | 2004-01-06 | Solvay Pharmaceuticals Gmbh | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins |
| CN104511127B (zh) * | 2013-09-30 | 2018-08-24 | 浙江宇安消防装备有限公司 | 一种d类火灾的灭火剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3081230A (en) * | 1960-09-08 | 1963-03-12 | Smith Kline French Lab | Diuretic and antihypertensive triaminoarylpteridines |
| US3113075A (en) * | 1960-10-17 | 1963-12-03 | Merck & Co Inc | Heterocyclic compounds |
| US3449496A (en) * | 1965-12-08 | 1969-06-10 | Smithkline Corp | Compositions and method for treating hypertensive patients comprising hydrochlorothiazide triamterene and reserpine |
| US4075335A (en) * | 1972-08-24 | 1978-02-21 | Ciba-Geigy Corporation | Pharmaceutical piperidine derivatives |
| US4323570A (en) * | 1978-11-15 | 1982-04-06 | Beiersdorf Aktiengesellschaft | Substituted aminopyrimidines |
| AU531659B2 (en) * | 1979-03-22 | 1983-09-01 | Goedecke Aktiengesellschaft | (+)-(3-methyl-4-oxo - 5n-piperidinothiazolidin-2-ylidene) acetic acid esters |
| US4681765A (en) * | 1984-09-13 | 1987-07-21 | American Home Products Corporation | Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use |
| DE3517820A1 (de) * | 1985-05-17 | 1986-11-20 | Röhm Pharma GmbH, 6108 Weiterstadt | Pharmazeutische praeparate mit antihypertensiver und kardioprotektiver wirkung |
| US4793999A (en) * | 1987-03-27 | 1988-12-27 | Sheth Prabhakar R | Method of manufacturing an antihypertensive, diuretic and antihypokalemic pharmaceutical composition with polyethylene glycol |
-
1987
- 1987-11-24 DE DE19873739779 patent/DE3739779A1/de not_active Withdrawn
-
1988
- 1988-11-12 DE DE8888118906T patent/DE3867042D1/de not_active Expired - Lifetime
- 1988-11-12 EP EP88118906A patent/EP0317855B1/de not_active Expired - Lifetime
- 1988-11-12 AT AT88118906T patent/ATE70445T1/de not_active IP Right Cessation
- 1988-11-17 US US07/272,667 patent/US4952410A/en not_active Expired - Fee Related
- 1988-11-17 AU AU25662/88A patent/AU2566288A/en not_active Abandoned
- 1988-11-21 JP JP63292542A patent/JPH01193224A/ja active Pending
- 1988-11-23 ES ES8803579A patent/ES2011186A6/es not_active Expired
- 1988-11-23 KR KR1019880015410A patent/KR890007740A/ko not_active Application Discontinuation
- 1988-11-24 ZA ZA888818A patent/ZA888818B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3867042D1 (de) | 1992-01-30 |
| US4952410A (en) | 1990-08-28 |
| EP0317855B1 (de) | 1991-12-18 |
| JPH01193224A (ja) | 1989-08-03 |
| ZA888818B (en) | 1989-08-30 |
| ATE70445T1 (de) | 1992-01-15 |
| EP0317855A3 (en) | 1990-05-02 |
| KR890007740A (ko) | 1989-07-05 |
| EP0317855A2 (de) | 1989-05-31 |
| AU2566288A (en) | 1989-05-25 |
| DE3739779A1 (de) | 1989-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA43318C2 (uk) | Похідні амідину, фармацевтична композиція з антагоністичною по відношенню до лейкотриєну в4 активністю | |
| SE8804629A (es) | ||
| IL124674A0 (en) | Piperazine derivatives pharmaceutical compositions containing the same and use thereof | |
| IE862554L (en) | Pharmaceutical compositions | |
| NZ244021A (en) | Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof | |
| EP0379806A3 (en) | Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines | |
| IL102764A0 (en) | Quinazoline derivatives,and pharmaceutical compositions containing them | |
| GR3025940T3 (en) | Heterocyclic derivatives of acylaminothiazole, their preparation and pharmaceutical compositions containing them. | |
| NZ239921A (en) | Substituted xanthine derivatives; medicaments. | |
| IL80437A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them | |
| FR2677984B1 (fr) | Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant. | |
| ZA881764B (en) | Thiazole derivatives active on the cholinerigic system,process for obtention and pharmaceutical compositions | |
| DE69801369D1 (de) | Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen | |
| IL101145A0 (en) | Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives | |
| NZ238288A (en) | Pyrazolo- and triazolo-(1,3,5)triazine derivatives; processes and pharmaceutical compositions | |
| NZ239514A (en) | Oxazole-substituted hydroxy-urea and cyclised hydroxy-urea derivatives, intermediate compounds and medicaments | |
| IE873125L (en) | Benzimidazole derivatives | |
| DE3877406T2 (de) | Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung. | |
| ES2011186A6 (es) | Procedimiento para la preparacion de composiciones farmaceuticas conteniendo moxonidina, hidroclotiazida, con o sin triamteren. | |
| DE68901859D1 (de) | 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung. | |
| EP0638080A4 (en) | PYRIMIDINE 7-BISUBSTITUEE-METHYL-4-OXO-3H -, 5H --PYRROLO 3,2-d -], PHARMACEUTICAL USE AND COMPOSITIONS CONTAINING SAID PYRIMIDINE. | |
| AU3957093A (en) | 3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxyl ic acid derivatives, preparation thereof and drugs containing same | |
| DE59001121D1 (en) | Antacidatabletten. | |
| EP0572308A3 (fr) | Dérivés hétérocycliques, leur procédé de préparation et les compositions qui les contiennent. | |
| IL99949A0 (en) | Heterocyclically substituted piperazino-alkylbenzoxazines and benzothiazines,their preparation and pharmaceutical compositions containing them |